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Background:   
  Differentiating Asthma with fixed airway from COPD is hard, due to similar 
symptom profile. Our attempts to understand the pathogenesis of these diseases started 
with Dutch hypothesis, which considers both Asthma/COPD as same spectrum, unlike 
the British hypothesis where Asthma and COPD are considered unique with no 
similarity(1). However, 'ACOS' Asthma COPD overlap Syndrome is even complicated. It 
has both Asthma, COPD features(2). ACOS has higher morbidity, more economic burden 
and poorer QOL recent studies say(3).  
 
Methods: 
   A prospective observational study done among diagnosed cases of Asthma and 
COPD in Pulmonary OPD review patients (> 6 months). Possible subjects were short 
listed prior to OPD. 60% patients were selected by simple randomization. Questionnaire 
was filled, X ray, spirometry, 6 MWT and other relevant investigations were reviewed. 
SPSS software was used for data analysis.  
 
 
 
Results: 
  Of 877 patients included in the study (M = 445, F = 432), 714 were diagnosed as 
Asthma, 156 as COPD and 7 patients as ACOS. Using the GINA Tool, 48 (5.4%) were 
truly ACOS. Of all asthma patients, 95.5% truly had asthma, 2.8% of them had ACOS 
and 1.7% had COPD. Of all COPD patients, 58% were truly COPD, 17.2% was ACOS 
and 24.8% was asthma. ACOS patients had more recurrent exacerbations than 
Asthma/COPD patients.  ACOS had more exacerbations, admissions and NIV use than 
asthma but lesser than COPD.   
  
Conclusion: 
  ACOS is widely prevalent in India as well. Gina tool is a wonderful instrument to 
differentiate Asthma, COPD and ACOS. 
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